Streetbeat News

Regulatory

SYRE

Paragon Therapeutics has granted Spyre Therapeutics an exclusive license to develop, manufacture, and commercialize antibodies targeting IL-23 for irritable bowel disease. Paragon will receive up to $22 million in milestone payments, including $2.5 million upon the first human dosing in a Phase 1 trial.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:41 am

HOTH

Hoth Therapeutics shares rise following the award of a US patent for its HT-ALZ Alzheimer's treatment. The company plans to prepare for clinical trials to validate its efficacy in humans.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:40 am

HOTH

Hoth Therapeutics has been awarded a US patent for its HT-ALZ Alzheimer's treatment. The company is preparing for clinical trials to validate the treatment's efficacy in humans.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:40 am

IBO

Impact BioMedical has announced a significant milestone with the issuance of a Canadian patent for its Linebacker technology, which targets inflammatory diseases. This development could enhance the company's intellectual property portfolio and potentially lead to new market opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:09 am

TSLA

Tech YouTuber MKBHD expressed skepticism about Tesla's timeline for delivering its Cybercab robotaxi before 2027, promising to shave his head if it happens. He highlighted the vehicle's features but questioned the feasibility of Tesla's promises, including the price and regulatory approval. Analysts share mixed views on Tesla's plans.

Portfolio Pulse from Ananya Gairola

October 15, 2024 | 9:47 am

BTCUSD

Market analyst Adam Cochran has outlined a wishlist for Kamala Harris to protect the cryptocurrency industry, including sacking SEC Chair Gary Gensler, legalizing user-operated wallets, and changing tax laws for crypto transactions. This comes as Harris unveils a cryptocurrency regulatory framework.

Portfolio Pulse from Aniket Verma

October 15, 2024 | 9:30 am

DBO

UCO

USO

China is urging Israel and Iran to de-escalate tensions to avoid further conflict, amid falling oil prices due to weak demand from China and geopolitical instability in the Middle East. This has impacted oil-related ETFs, with USO, DBO, and UCO experiencing significant declines.

Portfolio Pulse from Benzinga Neuro

October 15, 2024 | 9:23 am

LIPO

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) has received a notice of allowance from the USPTO for its liposomal drug delivery platform, marking a significant milestone in its development of therapies for serious diseases.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 9:09 am

VSAT

Viasat, Inc. (NASDAQ:VSAT) has successfully demonstrated direct-to-device satellite connectivity in India, showcasing two-way messaging services at the India Mobile Congress. This breakthrough, in partnership with BSNL, highlights the feasibility of satellite services for consumer and IoT devices, aligning with new global mobile standards.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:47 am

BABA

BIDU

FXI

MCHI

NIO

PGJ

TCHI

XPEV

China is considering issuing $850 billion in special treasury bonds to stimulate its economy and manage local debt. This news comes as U.S.-listed Chinese stocks, including Alibaba, Baidu, and JD.com, have seen declines due to unmet expectations for economic measures. ETFs like Invesco Golden Dragon China and iShares MSCI China Tech ETF have shown mixed performance.

Portfolio Pulse from Pooja Rajkumari

October 15, 2024 | 7:47 am